GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » PS Ratio

PharmaTher Holdings (XCNQ:PHRM) PS Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PharmaTher Holdings's share price is C$0.22. PharmaTher Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00. Hence, PharmaTher Holdings's PS Ratio for today is .

The historical rank and industry rank for PharmaTher Holdings's PS Ratio or its related term are showing as below:

During the past 3 years, PharmaTher Holdings's highest PS Ratio was 17.14. The lowest was 0.00. And the median was 0.00.

XCNQ:PHRM's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.22
* Ranked among companies with meaningful PS Ratio only.

PharmaTher Holdings's Revenue per Sharefor the three months ended in Feb. 2024 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00.

Back to Basics: PS Ratio


PharmaTher Holdings PS Ratio Historical Data

The historical data trend for PharmaTher Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings PS Ratio Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
PS Ratio
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's PS Ratio

For the Biotechnology subindustry, PharmaTher Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's PS Ratio falls into.



PharmaTher Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

PharmaTher Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.22/0
=

PharmaTher Holdings's Share Price of today is C$0.22.
PharmaTher Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


PharmaTher Holdings  (XCNQ:PHRM) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


PharmaTher Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines